Skip to main content
6 December 2019
Last updated:
Thursday 5 December 2019

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us

Research Directory

  • Acesion Pharma's new approach to atrial fibrillation

    Tuesday 1 May 2018
    Interviewee/Contributor
    Morten Grunnet
    Organisation
    Acesion Pharma ApS
    Drug discovery
    Strategy
    • Read more about Acesion Pharma's new approach to atrial fibrillation

Organisations

  • Marks & Clerk LLP
  • Novo Nordisk Biotech Fund
  • Max-Planck- Innovation GmbH
  • Marks & Clerk Solicitors LLP
  • Pfizer Regenerative Medicine
  • Paul Capital Healthcare
  • Lisman Legal Life Sciences
  • University of Medicine and Dentistry of New Jersey
  • Alpine Institute for Drug Discovery
  • Aduro Biotech Inc

Interviewees and Contributers

  • Dawn Firmin
  • Keith Flaherty
  • Keith Blundy
  • Rolf Günther
  • Mark Rothera
  • Anthony Sedgwick
  • Richard Goodfellow
  • Werner Lanthaler
  • J Fraser Wright
  • Wolfgang Kintzel

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Leonhard Stärk to advise Lysando on ethics
Monday October 7 2019
Macrophage appoints Søren Bregenholt as CEO
Monday October 7 2019
Christine Baker is CBO at Hookipa
Monday October 7 2019
Elcin Barker Ergun becomes CEO of Menarini Group
Monday October 7 2019
Jane Osbourn is chair of Mogrify board
Monday October 7 2019

© 2019 Evernow Publishing Ltd. Powered by Drupal.